JP5230647B2 - アミノチアゾール大環状分子、抗菌化合物としてのその使用およびその製造法 - Google Patents

アミノチアゾール大環状分子、抗菌化合物としてのその使用およびその製造法 Download PDF

Info

Publication number
JP5230647B2
JP5230647B2 JP2009542894A JP2009542894A JP5230647B2 JP 5230647 B2 JP5230647 B2 JP 5230647B2 JP 2009542894 A JP2009542894 A JP 2009542894A JP 2009542894 A JP2009542894 A JP 2009542894A JP 5230647 B2 JP5230647 B2 JP 5230647B2
Authority
JP
Japan
Prior art keywords
compounds
compound
acid
pharmaceutically acceptable
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2009542894A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010513512A5 (zh
JP2010513512A (ja
Inventor
マシュー・ジェイ・ラマーチェ
ジェニファー・エイ・リーズ
フィリップ・クラステル
ハンス−ウルリッヒ・ネーゲリ
Original Assignee
ノバルティス アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバルティス アーゲー filed Critical ノバルティス アーゲー
Publication of JP2010513512A publication Critical patent/JP2010513512A/ja
Publication of JP2010513512A5 publication Critical patent/JP2010513512A5/ja
Application granted granted Critical
Publication of JP5230647B2 publication Critical patent/JP5230647B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/185—Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2009542894A 2006-12-20 2007-12-19 アミノチアゾール大環状分子、抗菌化合物としてのその使用およびその製造法 Expired - Fee Related JP5230647B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US87105106P 2006-12-20 2006-12-20
US60/871,051 2006-12-20
US88959107P 2007-02-13 2007-02-13
US60/889,591 2007-02-13
US89298807P 2007-03-05 2007-03-05
US60/892,988 2007-03-05
PCT/US2007/025955 WO2008082562A2 (en) 2006-12-20 2007-12-19 Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production

Publications (3)

Publication Number Publication Date
JP2010513512A JP2010513512A (ja) 2010-04-30
JP2010513512A5 JP2010513512A5 (zh) 2010-09-16
JP5230647B2 true JP5230647B2 (ja) 2013-07-10

Family

ID=39166701

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009542894A Expired - Fee Related JP5230647B2 (ja) 2006-12-20 2007-12-19 アミノチアゾール大環状分子、抗菌化合物としてのその使用およびその製造法

Country Status (15)

Country Link
US (1) US8183341B2 (zh)
EP (1) EP2097423B1 (zh)
JP (1) JP5230647B2 (zh)
KR (1) KR20090082504A (zh)
CN (1) CN101563353B (zh)
AT (1) ATE500259T1 (zh)
AU (1) AU2007339279A1 (zh)
BR (1) BRPI0720542A2 (zh)
CA (1) CA2673506A1 (zh)
DE (1) DE602007012935D1 (zh)
EA (1) EA200900816A1 (zh)
MX (1) MX2009006745A (zh)
PL (1) PL2097423T3 (zh)
PT (1) PT2097423E (zh)
WO (1) WO2008082562A2 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200902540A (en) * 2007-06-04 2009-01-16 Novartis Ag Macrocycles and their uses
EA020205B1 (ru) 2007-12-12 2014-09-30 Новартис Аг Аминотиазолы, фармацевтические композиции на их основе и способы лечения бактериальной инфекции
JP2011116662A (ja) * 2008-03-26 2011-06-16 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 新規抗生物質ｓｆ２８７６物質、その製造法および医薬組成物
JP5756227B2 (ja) * 2011-04-18 2015-07-29 ミョンジ ユニヴァーシティ インダストリー アンド アカデミア コーペレーション ファウンデーション ノノムラエ種からの環状ペプチド、その生産プロセス、およびそれを含むマイコバクテリア関連疾病の治療または予防のための薬学的組成物
WO2014027821A1 (ko) * 2012-08-14 2014-02-20 한국화학연구원 스트랩토마이세스 스코풀리리디스 kr-001 균주, 또는 이의 배양액을 유효성분으로 포함하는 잡초 방제용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740299A (en) * 1985-05-14 1988-04-26 Parker Hannifin Corporation Filter assembly with threaded collection bowl
US5202241A (en) 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
ES2066914T3 (es) 1989-07-04 1995-03-16 Lepetit Spa Factores a1, a2, a3 y h del antibiotico ge 2270.
DE69108972T2 (de) 1990-03-08 1995-10-19 Lepetit Spa Antibiotika GE 2270 Faktoren B1, B2, C1, D1, D2, E und T.
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
ES2113391T3 (es) 1991-08-30 1998-05-01 Biosearch Italia Spa Factor c2a de antibiotico ge 2270.
US5882900A (en) 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
ES2112517T3 (es) 1992-12-22 1998-04-01 Biosearch Italia Spa Antibioticos ge 37468 a, b y c.
US5547686A (en) 1994-08-15 1996-08-20 Clemson University Feed supplements for ruminants and method for using same
AU3805295A (en) 1994-11-08 1996-05-31 Gruppo Lepetit S.P.A. Microbial transformation process for obtaining antibiotic ge 2270 factor d2
DK0808326T3 (da) 1995-02-07 2001-10-01 Biosearch Italia Spa Basiske oxazolinamidderivater af GE2270 og GE2270-lignende antibiotika
JP2825667B2 (ja) 1995-02-07 1998-11-18 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ Ｇｅ２２７０及びｇｅ２２７０−様抗生物質の塩基性プロリン−アミド誘導体
JP2000505438A (ja) 1996-02-14 2000-05-09 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ 抗生物質ＧＥ２２７０因子Ｃ▲下２ａ▼、Ｄ▲下２▼およびＥの誘導体
DE10160497A1 (de) * 2001-12-08 2003-06-12 Mann & Hummel Filter Verfahren und Vorrichtung zum Speichern von aus Kraftstoff ausgefiltertem Wasser
CA2489705C (en) 2002-06-17 2012-08-14 Vicuron Pharmaceuticals Inc. Use of amide derivative of ge 2270 factor a3 for the treatment of acne
CN101198318A (zh) * 2004-09-22 2008-06-11 默克公司 抗生素化合物
AR060977A1 (es) * 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos

Also Published As

Publication number Publication date
PL2097423T3 (pl) 2011-07-29
EP2097423A2 (en) 2009-09-09
EA200900816A1 (ru) 2009-12-30
PT2097423E (pt) 2011-06-01
KR20090082504A (ko) 2009-07-30
ATE500259T1 (de) 2011-03-15
JP2010513512A (ja) 2010-04-30
US8183341B2 (en) 2012-05-22
EP2097423B1 (en) 2011-03-02
CA2673506A1 (en) 2008-07-10
CN101563353B (zh) 2012-06-27
CN101563353A (zh) 2009-10-21
MX2009006745A (es) 2009-08-19
DE602007012935D1 (de) 2011-04-14
WO2008082562A2 (en) 2008-07-10
BRPI0720542A2 (pt) 2014-01-21
US20100093615A1 (en) 2010-04-15
AU2007339279A1 (en) 2008-07-10
WO2008082562A3 (en) 2008-11-13

Similar Documents

Publication Publication Date Title
JP5230647B2 (ja) アミノチアゾール大環状分子、抗菌化合物としてのその使用およびその製造法
AU745333B2 (en) Nocathiacin antibiotics
AU2010290872B2 (en) Antibiotic compounds
JP4538455B2 (ja) 抗生物質化合物
AU2007237861B2 (en) Novel antibacterial compounds
KR101344083B1 (ko) 폴리사이클릭 펩타이드 화합물을 포함하는 항균용 조성물 및 이의 생산방법
DE102004051023A1 (de) Desoxo-Nonadepsipeptide
JP2013542173A (ja) 新規抗菌性化合物、それらの作製法、およびそれらの使用
JP3830964B2 (ja) 海洋放線菌から単離した新規なチオデプシペプチド
ES2362456T3 (es) Macrociclos de aminotiazol, sus usos como compuestos antibacterianos y procesos para su producción.
JP4541405B2 (ja) 抗生物質化合物
CZ32694A3 (en) Purified form of streptogramins, process of its preparation and pharmaceutical preparations in which it is comprised
US7973147B2 (en) K04-0144 substance and a process for production thereof
EP0447494A1 (en) Altromycin compounds
NZ571636A (en) Novel antibacterial compounds comprising multiple thiazole rings isolated from Kocuria
EP0999212A1 (en) Furopyridine antibacterials
JP2006213703A (ja) 新規発酵生産物
WO2008024285A2 (en) Antibiotic compound

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120228

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120528

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121023

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130122

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130219

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130319

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160329

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees